However, high costs and regulatory hurdles could hinder its expansion. The global market for heart valve repair and ...

Registry seeks to evaluate the safety and effectiveness of the JenaValve Trilogy™ Heart Valve System in patients with left ventricular assist devices (LVADs) and clinically significant aortic ...

Traditionally, aortic valve replacement (AVR) is performed through open-heart surgery. However ... We take great pride in setting a new benchmark for cardiac interventions in the region.” Manipal ...

An 8-year-old Indiana girl will celebrate the holidays at home following a seven-month stay in the hospital after receiving a new heart in a real-life Christmas miracle.

Capstan Medical has raised $110m to advance its robotic platform for cardiac disease treatment in one of the larger medtech ...

A new study has found that microRNAs (miRNAs)—cellular RNA fragments that regulate gene expression—can be useful in ...

Capstan Medical Inc. closed an oversubscribed series C fundraising round that brought in $110 million for the structural heart-focused company. Capstan aims to combine valve implants, advanced ...

Scientists at Queen Mary University of London and Barts Health have developed an innovative tool that simulates blood flow in ...

Capstan Medical is developing a surgical robot and catheter-delivered cardiac implants for mitral and tricuspid heart valve ...

Capstan Medical, headquartered in the Wrigley Building on Santa Cruz's Westside, is heading to its first human trials with its minimally invasive treatment for heart valve disease.

Capstan Medical has reeled in $110 million to continue its mission of bringing robotic surgery to a previously untouched ...